Novira completes initial venture financing

Posted: March 26, 2013

Novira Therapeutics Inc., of Doylestown, has completed its initial $25 million venture financing, after attracting $7.5 million from Versant Ventures.

Founded by two former Merck & Co. Inc. executives, Novira is developing antiviral drugs to treat hepatitis B infections.

The addition of Versant, with offices in Basel, Switzerland, and San Francisco, increased the amount of the financing from $23 million, announced last August and led by 5AM Ventures and Canaan Partners.


Contact Mike Armstrong

at 215-854-2980 or marmstrong@phillynews.com, or @PhillyInc on Twitter. Read his blog, "PhillyInc," at www.phillyinc.biz.

 

comments powered by Disqus
|
|
|
|
|